Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jul 26;13(7):776-794.
doi: 10.4252/wjsc.v13.i7.776.

Exosomal microRNAs from mesenchymal stem/stromal cells: Biology and applications in neuroprotection

Aida Nasirishargh  1 , Priyadarsini Kumar  1 , Lalithasri Ramasubramanian  1 , Kaitlin Clark  1 , Dake Hao  1 , Sabrina V Lazar  1 , Aijun Wang  1
Affiliations
Review

Exosomal microRNAs from mesenchymal stem/stromal cells: Biology and applications in neuroprotection

Aida Nasirishargh et al. World J Stem Cells. .

Abstract

Mesenchymal stem/stromal cells (MSCs) are extensively studied as cell-therapy agents for neurological diseases. Recent studies consider exosomes secreted by MSCs as important mediators for MSCs' neuroprotective functions. Exosomes transfer functional molecules including proteins, lipids, metabolites, DNAs, and coding and non-coding RNAs from MSCs to their target cells. Emerging evidence shows that exosomal microRNAs (miRNAs) play a key role in the neuroprotective properties of these exosomes by targeting several genes and regulating various biological processes. Multiple exosomal miRNAs have been identified to have neuroprotective effects by promoting neurogenesis, neurite remodeling and survival, and neuroplasticity. Thus, exosomal miRNAs have significant therapeutic potential for neurological disorders such as stroke, traumatic brain injury, and neuroinflammatory or neurodegenerative diseases and disorders. This review discusses the neuroprotective effects of selected miRNAs (miR-21, miR-17-92, miR-133, miR-138, miR-124, miR-30, miR146a, and miR-29b) and explores their mechanisms of action and applications for the treatment of various neurological disease and disorders. It also provides an overview of state-of-the-art bioengineering approaches for isolating exosomes, optimizing their yield and manipulating the miRNA content of their cargo to improve their therapeutic potential.

Keywords: Exosomal microRNAs; Mesenchymal stromal cell-derived exosomes; Mesenchymal stromal cells; Neuroprotective effect.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest statement: The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Neuroprotective pathways regulated by mesenchymal stem/stromal cell-derived exosomes. A: Mesenchymal stem/stromal cell-derived exosomal miR-21; B: Mesenchymal stem/stromal cell-derived exosomal miR-17-92; C: Mesenchymal stem/stromal cell-derived exosomal miR-133.
Figure 2
Figure 2
Mesenchymal stem/stromal cell-derived exosomes overexpressing miR-138 repressed inflammatory and pro-apoptotic factors, and increased anti-apoptotic and cell cycle markers.
Figure 3
Figure 3
Neuroprotective pathways regulated by exosomal microRNAs. A: Exosomal miR-124; B: Exosomal miR-146a; C: Exosomal miR-29.
Figure 4
Figure 4
Exosomal miR-30 regulated autophagy-mediated brain injury by promoting anti-inflammatory (M2) macrophage polarization and suppressing pro-inflammatory macrophages (M1) polarization.
Figure 5
Figure 5
Neuroprotective effects and therapeutic potential of mesenchymal stem/stromal cell-derived exosomal miRNAs for neurological disorder disease models.
See this image and copyright information in PMC

References

    1. Zhang Y, Chopp M, Meng Y, Katakowski M, Xin H, Mahmood A, Xiong Y. Effect of exosomes derived from multipluripotent mesenchymal stromal cells on functional recovery and neurovascular plasticity in rats after traumatic brain injury. J Neurosurg . 2015;122:856–867. - PMC - PubMed
    1. Chen TS, Lim SK. Measurement of precursor miRNA in exosomes from human ESC-derived mesenchymal stem cells. Methods Mol Biol . 2013;1024:69–86. - PubMed
    1. Mishra VK, Shih HH, Parveen F, Lenzen D, Ito E, Chan TF, Ke LY. Identifying the Therapeutic Significance of Mesenchymal Stem Cells. Cells . 2020;9 - PMC - PubMed
    1. Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem . 2006;98:1076–1084. - PubMed
    1. Phinney DG, Di Giuseppe M, Njah J, Sala E, Shiva S, St Croix CM, Stolz DB, Watkins SC, Di YP, Leikauf GD, Kolls J, Riches DW, Deiuliis G, Kaminski N, Boregowda SV, McKenna DH, Ortiz LA. Mesenchymal stem cells use extracellular vesicles to outsource mitophagy and shuttle microRNAs. Nat Commun . 2015;6:8472. - PMC - PubMed